fda on semaglutide Approval vs Compounded Alternatives FDA warns about compounded versions

It is technically possible but generally not recommended, especially on injection day

How is the product sourced and quality-controlled

Its role in obesity treatment remains marginal-under 1% -but adoption is rising through clinical integrations and bundling with telehealth-based interventions targeting metabolic and appetite-related outcomes

Sales of Novos brand-name Wegovy are coming in lower than forecasted , while many patients are being prescribed compounded semaglutide

Neither of the component amino acids is sweet (Phe is actually bitter), and derivatives of the other dipeptide (Phe-Asp) are not sweet

It received UK approval in September 2022 and has a substantial safety record with millions of users worldwide